# Aptevo Therapeutics Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:2150d703-233d-4995-a080-b1bc3fc4ec98 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/aptevo-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 15 |
| Claims under review | 1 |
| Evidence records | 5 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-20T04:47:41.195601+00:00 |
| Last reviewed | 2026-10-20T04:47:41.195601+00:00 |

## Identity

- Legal name: Aptevo Therapeutics Inc.
- Display name: Aptevo Therapeutics Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-20T19:10:52.980065+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.826 |
| Directors | 7 |
| Committees | 1 |
| Governance events | 6 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Barbara Lopez Kunz: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:5
- Daniel J. Abdun-Nabi: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:6
- Grady Grant, III: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:7
- Marvin L. White: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2016-01-01. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:10
- Jeffrey G. Lamothe: President, Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer and Director (member). claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:8
- John E. Niederhuber, M.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:9
- Zsolt Harsanyi, Ph.D.: Director. Status: unknown. Independent: NOT_PUBLISHED. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:11

## Committees

- Chief Executive Officer and Director (executive). Chair: NOT_PUBLISHED. Members: Jeffrey G. Lamothe (member, unknown). committee_id=alpha:committee:aptevo-therapeutics-inc:chief-executive-officer-and-director

## Executive leadership

- Daphne Taylor: Senior Vice President, Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:12
- Marvin L. White: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:14
- Jeffrey G. Lamothe: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:13
- SoYoung Kwon: SVP, General Counsel, Business Development and Corporate Affairs [GC]. Status: unknown. claim_id=alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:15

## Governance events

- CFO_CHANGED: Daphne Taylor executive of Aptevo Therapeutics Inc., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-20T04:47:41.195601+00:00. event_id=alpha:event:transition:6590yq1sgqs64
- CEO_CHANGED: Marvin L. White executive of Aptevo Therapeutics Inc., effective 2026-03-26. Effective: 2026-03-26. Detected: 2026-10-20T04:47:41.195601+00:00. event_id=alpha:event:transition:5zb9bs1nvzcjw
- DIRECTOR_APPOINTED: Barbara Lopez Kunz seat on Aptevo Therapeutics Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-20T04:47:41.195601+00:00. event_id=alpha:event:transition:1axyk3vk7ewhf
- DIRECTOR_APPOINTED: Daniel J. Abdun-Nabi seat on Aptevo Therapeutics Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-20T04:47:41.195601+00:00. event_id=alpha:event:transition:osqyi1dr4n0
- DIRECTOR_APPOINTED: Grady Grant, III seat on Aptevo Therapeutics Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-20T04:47:41.195601+00:00. event_id=alpha:event:transition:q9zgal1azpvbt
- DIRECTOR_APPOINTED: Marvin L. White seat on Aptevo Therapeutics Inc., effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-20T04:47:41.195601+00:00. event_id=alpha:event:transition:1kvyuljbceqc7

## Scoped resources

- `alpha://company/aptevo-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record
- `alpha://company/aptevo-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=identity
- `alpha://company/aptevo-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=corporate-structure
- `alpha://company/aptevo-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=board
- `alpha://company/aptevo-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=committees
- `alpha://company/aptevo-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=leadership
- `alpha://company/aptevo-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=ownership
- `alpha://company/aptevo-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=financials
- `alpha://company/aptevo-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=capital-structure
- `alpha://company/aptevo-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=compensation
- `alpha://company/aptevo-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=governance
- `alpha://company/aptevo-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=shareholder-governance
- `alpha://company/aptevo-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=audit
- `alpha://company/aptevo-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=legal
- `alpha://company/aptevo-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=risk
- `alpha://company/aptevo-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=cyber
- `alpha://company/aptevo-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=ai-governance
- `alpha://company/aptevo-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=agents
- `alpha://company/aptevo-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=ecosystem
- `alpha://company/aptevo-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=events
- `alpha://company/aptevo-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=relationships
- `alpha://company/aptevo-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=assessments
- `alpha://company/aptevo-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Barbara Lopez Kunz: Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:5. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:39e1fe0c90511bfdcbb36354aa9d74ffe5428defce802071d65488b43d680f1c.
- Daniel J. Abdun-Nabi: Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:6. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:39e1fe0c90511bfdcbb36354aa9d74ffe5428defce802071d65488b43d680f1c.
- Grady Grant, III: Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:7. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:39e1fe0c90511bfdcbb36354aa9d74ffe5428defce802071d65488b43d680f1c.
- Jeffrey G. Lamothe: President, Chief Executive Officer and Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bda32c478888213f9bef14cff0d023d5fcfcb48496af346db69b1d9391ee01d8.
- John E. Niederhuber, M.D.: Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bda32c478888213f9bef14cff0d023d5fcfcb48496af346db69b1d9391ee01d8.
- Marvin L. White: Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:10. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:39e1fe0c90511bfdcbb36354aa9d74ffe5428defce802071d65488b43d680f1c.
- Zsolt Harsanyi, Ph.D.: Director. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bda32c478888213f9bef14cff0d023d5fcfcb48496af346db69b1d9391ee01d8.
- Daphne Taylor: Senior Vice President, Chief Financial Officer. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:12. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a7a603deb62a857178dc49c5c81ae4dc7eeca228e463a2683e5d6927da3ba9db.
- Jeffrey G. Lamothe: President and Chief Executive Officer. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bda32c478888213f9bef14cff0d023d5fcfcb48496af346db69b1d9391ee01d8.
- Marvin L. White: President and Chief Executive Officer. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:14. Valid from: 2026-03-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1212e87376d6719785aacdef22ba6e9d19f2ea077c46fd4bdffc248189dca55d.
- SoYoung Kwon: SVP, General Counsel, Business Development and Corporate Affairs. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:bda32c478888213f9bef14cff0d023d5fcfcb48496af346db69b1d9391ee01d8.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Aptevo Therapeutics Inc.. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:619964008c589bff10cd7fb42c4798e0630b3140d56731bfbce6d89ac42c5855.

## Entity Status

- Public listing published. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:619964008c589bff10cd7fb42c4798e0630b3140d56731bfbce6d89ac42c5855.

## Published Fact

- US. Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:619964008c589bff10cd7fb42c4798e0630b3140d56731bfbce6d89ac42c5855.

## Security Listing

- APVO (NASDAQ). Claim: alpha:claim:company:2150d703-233d-4995-a080-b1bc3fc4ec98:security_listing:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:619964008c589bff10cd7fb42c4798e0630b3140d56731bfbce6d89ac42c5855.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:619964008c589bff10cd7fb42c4798e0630b3140d56731bfbce6d89ac42c5855: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/aptevo-therapeutics-inc).
- alpha:projection-evidence:document:39e1fe0c90511bfdcbb36354aa9d74ffe5428defce802071d65488b43d680f1c: [Aptevo Therapeutics Inc. DEF 14A 2026-07-31](https://www.sec.gov/Archives/edgar/data/1671584/000119312526328604/apvo-20260731.htm).
- alpha:projection-evidence:document:bda32c478888213f9bef14cff0d023d5fcfcb48496af346db69b1d9391ee01d8: [SEC DEF 14A 0001193125-26-376763](https://www.sec.gov/Archives/edgar/data/1671584/000119312526376763/apvo-20260831.htm).
- alpha:projection-evidence:document:a7a603deb62a857178dc49c5c81ae4dc7eeca228e463a2683e5d6927da3ba9db: [APVO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1671584/000119312526126278/apvo-20251231.htm).
- alpha:projection-evidence:document:1212e87376d6719785aacdef22ba6e9d19f2ea077c46fd4bdffc248189dca55d: [APVO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1671584/000119312526126278/apvo-20251231.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/aptevo-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/aptevo-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/aptevo-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/aptevo-therapeutics-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-20T19:10:51.914582+00:00; recorded 2026-10-20T19:10:51.914582+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.